Healthcare provider profile · identity verified

Ernesto Cuna, MD

General Practice · HIALEAH, FL · NPI 1992106124

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	635	216
Losartan Potassium	Losartan Potassium	524	166
Levothyroxine Sodium	Levothyroxine Sodium	490	100
Rosuvastatin Calcium	Rosuvastatin Calcium	389	121
Amlodipine Besylate	Amlodipine Besylate	370	90
Alendronate Sodium	Alendronate Sodium	361	64
Lisinopril	Lisinopril	334	96
Gabapentin	Gabapentin	310	87
Famotidine	Famotidine	295	72
Metoprolol Succinate	Metoprolol Succinate	294	82
Metformin Hcl	Metformin Hcl	274	74
Hydrochlorothiazide	Hydrochlorothiazide	261	69
Metoprolol Tartrate	Metoprolol Tartrate	224	53
Omeprazole	Omeprazole	207	59
Eliquis	Apixaban	191	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	178	53
Tamsulosin Hcl	Tamsulosin Hcl	171	44
Clopidogrel	Clopidogrel Bisulfate	166	36
Albuterol Sulfate Hfa	Albuterol Sulfate	141	32
Montelukast Sodium	Montelukast Sodium	130	35
Glipizide Er	Glipizide	128	28
Simvastatin	Simvastatin	117	35
Fluticasone Propionate	Fluticasone Propionate	116	48
Glipizide	Glipizide	94	25
Clonidine Hcl	Clonidine Hcl	88	21
Lovastatin	Lovastatin	85	22
Azithromycin	Azithromycin	78	72
Pantoprazole Sodium	Pantoprazole Sodium	78	23
Baclofen	Baclofen	76	65
Irbesartan	Irbesartan	76	17
Donepezil Hcl	Donepezil Hcl	71	19
Memantine Hcl	Memantine Hcl	70	29
Finasteride	Finasteride	68	17
Atenolol	Atenolol	65	13
Carvedilol	Carvedilol	65	23
Enalapril Maleate	Enalapril Maleate	64	12
Furosemide	Furosemide	62	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	13
Nifedipine Er	Nifedipine	54	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	suppressed
Allopurinol	Allopurinol	51	13
Ammonium Lactate	Ammonium Lactate	50	15
Januvia	Sitagliptin Phosphate	50	suppressed
Alprazolam	Alprazolam	47	12
Doxazosin Mesylate	Doxazosin Mesylate	47	suppressed
Ciclopirox	Ciclopirox	45	suppressed
Meloxicam	Meloxicam	42	39
Amiodarone Hcl	Amiodarone Hcl	41	suppressed
Entresto	Sacubitril/Valsartan	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	36
Janumet	Sitagliptin Phos/Metformin Hcl	34	suppressed
Latanoprost	Latanoprost	34	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Tradjenta	Linagliptin	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	13
Temazepam	Temazepam	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Methylprednisolone	Methylprednisolone	27	24
Xarelto	Rivaroxaban	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	14
Anastrozole	Anastrozole	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Ketoconazole	Ketoconazole	20	14
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	20
Ciclopirox	Ciclopirox Olamine	19	suppressed
Lactulose	Lactulose	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Cephalexin	Cephalexin	17	17
Glimepiride	Glimepiride	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Naproxen	Naproxen	17	14
Potassium Chloride	Potassium Chloride	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Acarbose	Acarbose	13	suppressed
Clonidine	Clonidine	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Mupirocin	Mupirocin	13	13
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Veltassa	Patiromer Calcium Sorbitex	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error